Primary percutaneous coronary intervention in acute myocardial infarction: Is there a difference in the outcomes of normal and off-hours procedures?;Angioplastia primária no infarto agudo do miocárdio: Existe diferença de resultados entre as angioplastias realizadas dentro e fora do horário de rotina?

Revista Brasileira de Cardiologia Invasiva

Volumn 18, Issue 3, 2010, Pages

  Cardoso, Cristiano De Oliveira ^a   De Quadros, Alexandre Schaan ^a   Voltolini, Ismael ^a   Azmus, Alexandre Damiani ^a   Cardoso, Carlos Roberto ^a   Sebben, Juliana ^a   Welter, Dulce ^a   Abelin, Anibal Pereira ^a   Rover, Marciane ^a   Baldissera, Felipe ^a   Bosco, Márcio ^a   Rodrigues, Délcio ^a   Dutra, Oscar Pereira ^a   Peñalosa, Mário ^a   Sarmento Leite, Rogério ^a   Gottschall, Carlos A M ^a  

^a INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

Author keywords

Angioplasty; Myocardial infarction; Myocardial reperfusion

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; FEMALE; HEART RATE; HEART REINFARCTION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROGNOSIS; STENT THROMBOSIS; TIME;

EID: 78049283921     PISSN: 01041843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1(8478):397-402.
2. Second International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2(8607):349-60.
3. O'Neill W, Timmis GC, Bourdillon PD, Lai P, Ganghadarhan V, Walton J Jr, et al. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. N Engl J Med. 1986;314(13):812-8. (Pubitemid 16138680)
4. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003;349(8):733-42. (Pubitemid 37010777)
5. Grines C, Patel A, Zijlstra F, Weaver WD, Granger C, Simes RJ. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. Am Heart J. 2003;145(1):47-57. (Pubitemid 36034497)
6. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13-20. (Pubitemid 36050955)
7. Mattos LA, Lemos Neto PA, Rassi Junior A, Marin-Neto JA, Souza AGMR, Devito FS. Diretrizes da Sociedade Brasileira de Cardiologia: intervenção coronária percutânea e métodos adjuntos diagnósticos em cardiologia intervencionista (II Edição 2008). Rev Bras Cardiol Invasiva. 2008;16(2 Supl 2):9-88.
8. Nielsen PH, Maeng M, Busk M, Mortensen LS, Kristensen SD, Nielsen TT, et al. Primary angioplasty versus fibrinolysis in acute myocardial infarction: long-term follow-up in the Danish acute myocardial infarction 2 trial. Circulation. 2010;121(13):1484-91.
9. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328(10):680-4. (Pubitemid 23073369)
10. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004;110(5):588-636.
11. rd, Anderson JL, Antman EM, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;120(22):2271-306.
12. De Luca G, Suryapranata H, Ottervanger JP, van't Hof AW, Hoorntje JC, Gosselink AT, et al. Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Am Heart J. 2005;150(6):1185-9.
13. Henriques JP, Haasdijk AP, Zijlstra F. Outcome of primary angioplasty for acute myocardial infarction during routine duty hours versus during off-hours. J Am Coll Cardiol. 2003;41(12):2138-42.
14. Saleem MA, Kannam H, Aronow WS, Weiss MB, Kalapatapu K, Pucillo AL, et al. The effects of off-normal hours, age, and gender for coronary angioplasty on hospital mortality in patients undergoing coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004;93(6):763-4. (Pubitemid 38338573)
15. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, et al. Universal definition of myocardial infarction. Circulation. 2007;116(22):2634- 53.
16. Uyarel H, Ergelen M, Akkaya E, Ayhan E, Demirci D, Gul M, et al. Impact of day versus night as intervention time on the outcomes of primary angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv. 2009;74(6):826-34.
17. Kostis WJ, Demissie K, Marcella SW, Shao YH, Wilson AC, Moreyra AE. Weekend versus weekday admission and mortality from myocardial infarction. N Engl J Med. 2007;356(11):1099-109. (Pubitemid 46437101)
18. McNamara RL, Wang Y, Herrin J, Curtis JP, Bradley EH, Magid DJ, et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2006;47(11):2180-6. (Pubitemid 43810139)
19. Roe MT, Messenger JC, Weintraub WS, Cannon CP, Fonarow GC, Dai D, et al. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol. 2010;56(4):254-63.
20. Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Aquilina M, et al. Clinical comparison of "normalhours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. Am Heart J. 2007;154(2):366-72.
21. Brodie BR, Gersh BJ, Stuckey T, Witzenbichler B, Guagliumi G, Peruga JZ, et al. When Is Door-to-Balloon Time Critical? Analysis From the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials. J Am Coll Cardiol. 2010;56(5):407-13.
22. Widimsky P, Wijns W, Fajadet J, de Belder M, Knot J, Aaberge L, et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J. 2010;31(8):943-57.
23. Bradley EH, Herrin J, Wang Y, Barton BA, Webster TR, Mattera JA, et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med. 2006;355(22):2308-20. (Pubitemid 44837779)